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Glucocorticoids act by binding to the glucocorticoid
receptor (GR), which binds to specific motifs within
enhancers of target genes to activate transcription.
Previous studies have suggested that GRs can pro-
mote interactions between gene promoters and
distal elements within target loci. In contrast, we
demonstrate here that glucocorticoid addition to
mouse bone-marrow-derived macrophages pro-
duces very rapid chromatin unfolding detectable by
fluorescence in situ hybridization (FISH) at loci asso-
ciated with GR binding. Rapid chromatin decompac-
tion was generally not dependent on transcription at
those loci that are known to be inducible in both
mouse and human macrophages and was sustained
for up to 5 days following ligand removal. Chromatin
decompaction was not dependent upon persistent
GR binding, which decayed fully after 24 hr. We sug-
gest that sustained large-scale chromatin reorgani-
zation forms an important part of the response to
glucocorticoid and might contribute to glucocorti-
coid sensitivity and resistance.
INTRODUCTION
Glucocorticoids (GCs) areclinically importantmetabolic hormones
with powerful anti-inflammatory effects. They are among themost
widely prescribed therapeutic agents, but cardio-metabolic side
effects and resistance limit their therapeutic use. Furthermore,
GC resistance emerges in many patients with chronic inflamma-
tory disease, and the basis of the lack of efficacy in acute inflam-
mation associatedwith sepsis is notwell understood (Dendoncker
and Libert 2017; Rodriguez et al., 2016). Dysregulation of endoge-
nousGCsduringsevere illnesshasbeen linked toworseoutcomes
(Annane et al., 2000; Boonen et al., 2013).
GCs act by binding to the glucocorticoid receptor (GR)
(Nr3c1), which is a ligand-activated transcription factor (TF).
Macrophages express GR at high levels (Forrest et al., 2014; Lat-
tin et al., 2008) and aremajor targets of the anti-inflammatory and3022 Cell Reports 21, 3022–3031, December 12, 2017 ª 2017 The A
This is an open access article under the CC BY license (http://creativetherapeutic impacts of GC treatment (Jubb et al., 2016; Oh et al.,
2017). Although there is evidence for direct trans-repression of
pro-inflammatory genes by GCs (Uhlenhaut et al., 2013), the ma-
jor mechanism of action appears to involve induction of feed-
back regulators, such as Dusp1, IkBa, Tnfaip3, and Tsc22d3
(Jubb et al., 2016; Oh et al., 2017; Reddy et al., 2009; Vandevyver
et al., 2012). As an inducer of gene expression, GR binds in a
ligand-dependent manner to DNA at sites (enhancers) that may
lie many tens of kilobases from the target gene (Lim et al.,
2015; Jubb et al., 2016; Reddy et al., 2009; So et al., 2007; Stav-
reva et al., 2015; Uhlenhaut et al., 2013). GR binding is largely
constrained to sites accessible to nuclease digestion and is
associated with the nearby binding sites for pioneer TFs (Belikov
et al., 2009; Biddie et al., 2011; Grøntved et al., 2013; Jubb et al.,
2016; Starick et al., 2015). As a consequence, GR target genes
can vary between tissue and cell types. In the case of macro-
phages, GR binding is strongly associated with binding sites
for the macrophage lineage TF PU.1 (Jubb et al., 2016; Oh
et al., 2017), and further binding sites become available upon in-
flammatory activation, associated with AP1 and RelA binding
(Oh et al., 2017). The transcriptional response of macrophages
to GCs varies markedly between humans and mice, associated
with the gain and loss of GR binding sequence motifs (Jubb
et al., 2016). GR binding can also initiate the formation of a
more nuclease-sensitive local chromatin structure (Biddie
et al., 2011; Burd and Archer 2013; John et al., 2008; Hakim
et al., 2011; Stavreva et al., 2015). This may be transient, disap-
pearing rapidly upon hormone withdrawal, or may persist well
beyond the period of hormone treatment (Stavreva et al., 2015).
As well as altering local nucleosome structure, some nuclear
hormone receptors, such as the estrogen receptor, can modu-
late chromatin structure at a scale sufficiently large to be detect-
able by light microscopy (Nye et al., 2002; Rafique et al., 2015).
There have been few reports on GR actions at this level of chro-
mosome structure. At a repetitive array of the mouse mammary
tumor virus (MMTV) promoter, GR binding results in transcrip-
tion-dependent visible chromatin decompaction over the course
of a few hours (M€uller et al., 2001). Conversely, 4C chromatin
conformation capture assays of the GR-responsive Lcn2 locus
in a mammary adenocarcinoma cell line indicated that GR bind-
ing produced only amodest effect on long-range chromatin con-
tacts captured with this approach (Hakim et al., 2011).uthor(s).
commons.org/licenses/by/4.0/).
Figure 1. GC Causes Rapid and Prolonged
Chromatin Decompaction at the Fkbp5
Locus
(A) Expression data in response to 100 nM dexa-
methasone (Dex) for Fkbp5 at the time points indi-
cated (Jubb et al., 2016). Dx, treated for 2 hr, then
washout for 22 hr; V, vehicle treated and washout
22 hr. Yellow rectangle highlights the static level of
stablemRNAby1hr. Expression ispresented as the
raw normalized intensity values from microarrays.
(B) Genome browser image showing Fkbp5 locus
with ChIP-seq data (tags/bp) for GR binding from
Jubb et al. (2016). Red and green blocks show the
positions of FISH probes. Genome map positions
are from themm9 assembly of the mouse genome.
Positions of primers used for ChIP-qPCR are
shown (+65 kb, promoter, 28 kb).
(C) Glucocorticoid receptor (GR) binding measured
by ChIP-qPCR for the downstream enhancer
(+65 kb), promoter andupstreamenhancer (28 kb)
of Fkbp5 and a control site in the Actb promoter.
Data are shown for a four-point time series (base-
line, 5 min, 15 min,1 hr) of treatment with 100 nM
Dex. IgG control ChIP is also shown. Error bars are
23 SEM for three technical replicates (a further
biological replicate is shown in Figure S1B).
(D) 3D DNA FISH images of nuclei from mBMDM
treated with 100 nM Dex or vehicle control for
5 min using the probes indicated in (A). Scale bar
represents 1 mm.
(E) Boxplots of inter-probe distances (mm) mea-
sured across the Fkbp5 locus at the indicated times
following treatment with vehicle or 100 nM Dex;
n = 80 for each condition. Horizontal line, median;
whiskers, 1.53 interquartile range; *p < 0.05,
**p < 0.005, ***p < 0.0005, Wilcoxon rank sum.
(F) As for (E) but after culturing for prolonged pe-
riods after Dex washout.
(G) GR binding measured by ChIP-qPCR for the Fkbp5 downstream enhancer (+65 kb) and Actb promoter following stimulation with 100 nM Dex at 1 and 24 hr
with (1h+23w) and without (24h) washout of the ligand. Error bars are 23 SEM for three technical replicates (a further biological replicate is shown in Figure S1C).We previously identified inducible sites of GR binding at likely
enhancers of genes induced byGC in primarymouse and human
macrophages (Jubb et al., 2016). Here, using fluorescence in situ
hybridization (FISH), we demonstrate rapid, persistent, and
visible chromatin decompaction—increases in inter-probe
distances—at multiple GC-responsive loci in mouse bone-
marrow-derived macrophages (mBMDMs) following dexameth-
asone treatment. We compare and contrast the behavior of
loci in which the GC response is conserved in mice and humans
with loci whose response to GC is specific to mouse macro-
phages. Our data provide insight into howGCs affect large-scale
chromatin structure in macrophages and indicate that there may
be a long-term ‘‘memory’’ of GR binding on chromatin.
RESULTS
GC Induces Rapid GRBinding at Enhancers at the Fkbp5
Locus
We have previously generated genome-wide expression and GR
binding data in primary mouse and human macrophages re-
sponding to 100 nM dexamethasone (Dex), a GR agonist (Jubb
et al., 2016). These GR binding sites bear the hallmarks of en-hancers, being enriched in PU.1 binding sites, and active
enhancer histone marks in unstimulated mBMDMs (Ostuni
et al., 2013) (Figure S1A). Many GC-inducible genes were regu-
lated only in one species or the other, associated with gain and
loss of GR motifs from the respective genome. Even for genes
that were induced in both species, the precise site of GR binding
was not always conserved. In this study, we first focused on
Fkbp5, a GR co-chaperone and inducible feedback regulator
of the GC response. Elevated Fkbp5 levels reduce the affinity
of GR for the agonist and are associated with resistance (Denny
et al., 2000; Ja¨a¨skela¨inen et al., 2011; Vandevyver et al., 2012;
Zannas et al., 2016).
Fkbp5 is strongly induced by Dex in both mouse and human
macrophages. The time course of Fkbp5 mRNA induction in
BMDMs is shown in Figure 1A. In human A549 lung carcinoma
cells, GR binding sites have been described 34 kb 50 and 87
kb 30 of the FKBP5 transcription start site (TSS) (Reddy et al.,
2009). In human macrophages, we also identified two major
GR binding sites in similar locations (Jubb et al., 2016). In
mBMDMs, chromatin immunoprecipitation sequencing (ChIP-
seq) revealed strong GR binding at a site 28 kb upstream of
Fkbp5 (28 kb) and at an intragenic site (+65 kb) after 1 hr ofCell Reports 21, 3022–3031, December 12, 2017 3023
Figure 2. Delayed and Transient Chromatin Decompaction in Response to GC at Tmod1
(A) Expression data in response to 100 nM Dex for Tmod1 at the time points indicated (Jubb et al., 2016). Expression is presented as the raw normalized intensity
values from microarrays.
(B) Genome browser image showing GR ChIP-seq data for Tmod1 locus (Jubb et al., 2016) and the position of probes used for DNA FISH.
(C) 3D DNA FISH images of nuclei from mBMDM 4 hr after treatment with vehicle or 100 nM Dex using the probes indicated in (B). Scale bar represents 1 mm.
(D) Inter-probe distances (mm) measured across Tmod1 locus at the indicated times following treatment with 100 nM Dex; n = 80 for each condition. Boxplots
shown as in Figure 1.Dex exposure (Figure 1B). As seen for most GC-responsive
genes in macrophages from both species (Jubb et al., 2016),
no GR binding was detected at the Fkbp5 promoter. Both GR
enhancer locations in the two species correspond to putative en-
hancers based upon the bidirectional transcription of enhancer-
associated enhancer RNA (eRNA) (Andersson et al., 2014). The
kinetics of GR binding and loading of chromatin remodeling
complexes in cell lines indicate that conformational changes
induced by GC may be rapid—within minutes (Johnson et al.,
2008; Nagaich et al., 2004; Voss et al., 2011). To examine these
kinetics in macrophages, we measured GR binding at the Fkbp5
locus over a 1-hr time course. There was evidence of GR binding
at either enhancer within 5 min of Dex addition. Maximal binding
at the28-kb element occurred by 15min (Figures 1C and S1B),
while binding at +65 kb had slower kinetics, being detectable by
15 min and increasing 1 hr after Dex addition.
GR Binding Is Associated with Rapid and Persistent
Chromatin Decompaction at Fkbp5
To better understand the relationship between GR binding
and long-range chromatin structure, we analyzed chromatin
compaction by 3D DNA-FISH (Eskeland et al., 2010; Williamson
et al., 2014) using one probe overlapping the 28-kb enhancer3024 Cell Reports 21, 3022–3031, December 12, 2017and extending to the Fkbp5 promoter, and another lying just
beyond the +65-kb enhancer (Figure 1B). Following Dex treat-
ment of mBMDMs, there was a rapid (<5-min) increase in the
average inter-probe distances measured across the Fkbp5
locus (Figures 1D and 1E). We will refer to this phenomenon
as locus decompaction. Figure S2 shows further illustrative im-
ages, with and without Dex treatment, from each of the loci
tested here. Chromatin decompaction across the Fkbp5 locus
preceded detectable increased stable Fkbp5 mRNA production
(Figure 1A) and was maintained even after 24 hr (Figure 1E). To
determine whether chromatin decompaction persists beyond
the initial exposure period, Dex was washed out from the culture
medium. Fkbp5 mRNA levels returned to near baseline within
24 hr of washout (Figure 1A). However, chromatin decompac-
tion persisted for 5 days after ligand washout (Figure 1F). Sur-
prisingly, ChIP showed that GR binding at the +65-kb enhancer
is transient, decaying completely after 24 hr, regardless of
whether Dex was washed out after 1 hr (Figures 1G and S1C).
These data suggest that GR binding has a direct and long-last-
ing effect on large-scale chromatin structure at the Fkbp5 locus
that occurs before the appearance of Fkbp5mRNA and persists
after Fkbp5 mRNA is no longer produced, and after GR binding
is lost.
Figure 3. Rapid and Sustained Chromatin Decompaction in Response to GC at a Multi-gene Locus
(A) Expression time course data for theGC-regulated genes in theMs4xxx locus. Expression is presented as the raw normalized intensity values frommicroarrays.
(B) Genome browser image showing GR ChIP-seq data from mBMDM for Ms4xxx locus (Jubb et al., 2016) and the position of probes used for DNA FISH.
(C) 3D DNA FISH images of nuclei from mBMDM 15min after treatment with vehicle or 100 nM Dex, using the probes indicated in (B). Scale bar represents 1 mm.
(D) Inter-probe distances (mm)measured across theMs4xxx locus at the indicated times following treatment with 100 nMDex; n = 80 for each condition. Boxplots
shown as in Figure 1.Chromatin Decompaction Is Slow and Transient at a
GC-Responsive Locus Where GR Is Not Bound
Most, but not all, GC-inducible genes in mBMDMs have detect-
able GR bound in their vicinity (±1,000 kb) (Jubb et al., 2016).
For responsive genes without detectable GR binding in the gen-
eral vicinity, transcriptional activation is likely to be a secondary
consequence of GC induction of TFs. Eight of the GC-inducible
genes in macrophages encode TFs, including four (Fos, Hivep2,
Klf4, and NcoA5) that were induced within 2 hr and might
contribute to downstream target gene induction. The Tmod1 lo-
cus, which shares the same kinetics of gene activation in
response to Dex as Fkbp5 (Figure 2A), did not show evidence
of regulated GR binding anywhere within its immediate vicinity
(Figure 2B), or indeed anywhere within the wider Mb domain
that likely encompasses an entire topologically associated
domain (Figure S3) (Dixon et al., 2012). By contrast to the rapid
and sustained effect at Fkbp5, FISH indicated that chromatin
decompaction across the Tmod1 locus in response to GC
occurred more slowly (1–4 hr), paralleled the kinetics of
mRNA induction, and was not sustained at 24 hr (Figures 2C
and 2D).Rapid Chromatin Decompaction Occurs at Multiple Loci
Fkbp5 has a specific role in feedback control of the response to
GCs, and so could have a unique mode of regulation. We there-
fore analyzed several other GR-bound loci that differ in whether
the response to GCwas conserved across species. One of these
is a large (720-kb) cluster of genes for the tetraspanin family of
transmembrane proteins (referred to here as Ms4xxx). A peak
of Dex-induced GR binding is located in the center of theMs4xxx
cluster, between Ms4a7 and Ms4a4c (Figure 3B). Interestingly,
Ms4a4c and Ms4a4b, close to the GR binding site, are not
induced by GC, but the more distant Ms4a6b, Ms4a6c, and
Ms4a6d were significantly induced by Dex, albeit more slowly
than for Fkbp5 (Figure 3A). Ms4a family members were also
induced in human macrophages, also associated with GR bind-
ing to the locus (Jubb et al., 2016). Despite the slower kinetics of
gene induction, FISH revealed that, as seen at Fkbp5, there was
rapid (within 5 min) and sustained chromatin decompaction
across the central part of the Ms4xxx locus after Dex treatment
(Figures 3C and 3D and S2).
A third example of a conserved GR-inducible locus was Klhl6/
B3gnt5/Klhl24 (Figure S4A), where all three transcripts wereCell Reports 21, 3022–3031, December 12, 2017 3025
Figure 4. Rapid and Sustained Chromatin Decompaction May Be a Feature of Loci That Are Conserved in Their GC Response
(A) 3D DNA FISH images at the Klhl6/B3gnt5 locus of nuclei from mBMDMs 15 min after treatment with vehicle or 100 nM Dex. Probe positions shown in Fig-
ure S4A. Scale bar represents 1 mm.
(B–D) Boxplots of the inter-probe distances (mm) measured across the Klhl6/B3gnt5 (B), Tns1 (C), and Dst (D) loci at the indicated times following treatment with
vehicle or 100 nM Dex; n = 120 for each condition. Boxplots as in Figure 1.
(E) GR binding measured by ChIP-qPCR at Tns1 andMs4xxx loci and Actb promoter following stimulation with 100 nM Dex. Data are shown for 1 and 24 hr with
(1h+23w) and without (24h) washout of the ligand. Error bars are 23 SEM for three technical replicates (a biological replicate is shown in Figure S5).induced by Dex. Here again, we observed rapid locus decom-
paction upon addition of Dex that was sustained for at least
24 hr (Figures 4A and 4B, images from further time points are
shown in Figure S2).
We speculated that genes induced by GC only in one
species (mouse or human), but not both, might exhibit distinct
modes of induction. Accordingly, we examined two loci—
Tns1, which had a local GR peak, and Dst, which did not—
induced by Dex in mBMDMs but not in human monocyte-
derived macrophages (Figures S4B and S4C). Dex induced
rapid chromatin decompaction at these two loci, but by
contrast with loci with conserved GC responses between spe-
cies, this was not sustained beyond the first 5 min (Figures 4C
and 4D).
As observed at the Fkbp5 (+65) enhancer, the sustained chro-
matin decompaction observed at the Ms4xxx locus was not
associated with continuous GR binding. GR binding was unde-
tectable at both theMs4xxx and Tns1 loci after 24 hr, regardless
of whether or not the agonist was washed out after 1 hr (Figures
4E and S5).3026 Cell Reports 21, 3022–3031, December 12, 2017Rapid Chromatin Decompaction at GR-Bound Loci Can
Occur without Transcription
Chromatin at actively transcribed regions is generally less
compact than at silenced regions (Chambeyron and Bickmore
2004; Naughton et al., 2013). Therefore, the decompaction we
observed in response to Dex could be a consequence of, rather
than causally linked to, transcriptional activation induced by
GR.The rapidity of the response (within5min) and thepersistence
long after loss of GR binding (Figure 4E) and target gene inactiva-
tion, argue against the simple proposition that chromatin decom-
paction is associated with the act of transcription. However, to
test this directly, we used a-amanitin to inhibit transcription by
RNAPolymerase II. At Tmod1, where the induction by Dex is pre-
sumed to be indirect given the lack of GR binding (Figures 2B and
S3), pre-treatment ofmBMDMwitha-amanitin for 4 hr ablated the
Dex-dependent changes in chromatin compaction (Figures 5A
and 5B). Unexpectedly, a-amanitin also prevented detectable
chromatin changes at Klhl6/B3gnt5 (Figure 5C). This suggests
either that this response is associated with transcription directly,
or that it depends upon a labile regulator that decays, or is not
Figure 5. a-Amanitin Does Not Block Rapid Chromatin Unfolding at GR-Bound Loci
(A) 3D DNA FISH images using probes across the Tmod1 locus (Figure 2A) in nuclei from mBMDM that have been pretreated with 2.5 mg/mL a-amanitin for 4 hr,
and then treated with 100 nM Dex for the indicated time. Scale bar represents 1 mm.
(B) Inter-probe distances measured across Tmod1 locus after pretreatment with a-amanitin for 4 hr and then treatment with 100 nM Dex for the indicated times.
n = 120 for each dataset. *p < 0.05, Wilcoxon rank sum.
(C–E) Analogous to (B) but measured across the (C) Klhl6/B3gnt5, (D) Fkbp5, and (E) Ms4xxx loci.
(F) 3D DNA FISH images using probes across the Fkbp5 locus (Figure 1B) showing nuclei frommBMDMs that have been pretreated with 2.5 mg/mL a-amanitin for
4 hr, and then treated with 100 nM Dex for the indicated time. Scale bar represents 1 mm.produced, in the presence of the inhibitor (Stacey et al., 1994).
Although the GR-bound enhancer at the Klhl6/B3gnt5 locus has
conserved GR and PU.1 consensus motifs, its GR-ChIP-seq
peak is weaker than those at the Fkbp5 and Ms4xxx loci. By
contrast, Dex still induced significant chromatin decompaction
at the Fkbp5 (Figures 5D and 5F) and theMs4xxx loci (Figure 5E)
in the presence of a-amanitin, albeit with slightly delayed kinetics.DISCUSSION
Single-cell imaging indicates that the binding of the GR, and
associated coactivators that recruit chromatin remodeling
complexes (GRIP1, BRG1), is dynamic and rapidly reversible
(Paakinaho et al., 2017). In the present study, we have
shown that GC produces very rapid changes to higher-orderCell Reports 21, 3022–3031, December 12, 2017 3027
Table 1. Primers
Locus Sequence
Fkbp5 28 kb, forward GAACACAGTGTCCCCCAGAG
Fkbp5 28 kb, reverse CAGGAGAGGAGGAGAGGGTC
Fkbp5 promoter, forward TTTGCATCTCCGCCTCTTCA
Fkbp5 promoter, reverse TCCTCCATCCCTCTTCTCCG
Fkbp5 +65 kb, forward GCCAAGTTCAGCTGTGCAAT
Fkbp5 +65 kb, reverse TGCCAGCCACATTCAGAACA
Tns1, forward GCAGTTTGGAGCCAAAAAGACC
Tns1, reverse TGGGTCTGAGCAATTCCAGTTC
Ms4xxx, forward TGTTAATGGTGGCGTGAGAGTG
Ms4xxx, reverse ATAAGACGTGGTACTGCCTGAG
Actb promoter, forward CTAGCCACGAGAGAGCGAAG
Actb promoter, reverse CGCGAGCACAGCTTCTTTchromatin structure in macrophages at genomic sites where
GR binds directly to DNA. Moreover, these changes persist
for prolonged periods beyond the exposure to GC and do not
depend upon the continuous presence of bound GR. It has
been suggested that GR occupancy patterns in different cell
types are predetermined by the distinctive baseline nucleo-
some accessibility patterns, a significant minority of which are
then altered after GC treatment (John et al., 2011). Local tran-
sient GR binding can promote subsequent binding of a variant
GR to the same motif, a phenomenon referred to as ‘‘assisted
loading’’ (Voss et al., 2011).
Sustained chromatin reorganization in response to GR is not
universal among target loci. The three genes tested that were
induced only in mice, Tns1, Tmod1, and Dst, showed decom-
paction in response to Dex, but this was not sustained (Figures
4C and 4D), even though one of these (Tns1) has a GR-bound
enhancer. The observation that most, but not all, inducible
DNase I hypersensitive sites (DHSs) revert to the pre-stimulation
state following GR stimulation (Stavreva et al., 2015) suggests
that these genes are in the majority.
The rapid chromatin decompaction we report at multiple
GR-responsive loci is distinct from previous reports. Transient
chromatin reorganization of the MMTV array detected following
GC exposure could be prevented by blocking transcription
(M€uller et al., 2001). However, lack of effect of a-amanitin at
one-half of the loci we studied (Figure 5) suggests that tran-
scription, per se, is not absolutely required for GR-induced
decompaction.
At first sight, GR-induced chromatin decompaction at the
Fkbp5 locus conflicts with evidence of the formation of a
compact loop domain in GC-responsive loci inferred in other
systems (Paakinaho et al., 2010; Klengel et al., 2013). However,
chromosome conformation capture and FISH assays can give
apparently discordant views of spatial genome organization
(Fraser et al., 2015; Williamson et al., 2014) and chromatin
decompaction could still be permissive for transient, rather
than stable, interactions between elements that can be
captured by 3C methods. We cannot exclude that the decom-
paction we observe represents GC-induced dissolution of pre-
formed chromatin loops. The action of the GR that we report3028 Cell Reports 21, 3022–3031, December 12, 2017here is reminiscent of large-scale chromatin decompaction
induced by other nuclear hormone receptors: the ecdysone
receptor, which induces visible chromatin decompaction
(puffing) on Drosophila polytene chromosomes (Tulin and Spra-
dling, 2003; Sawatsubashi et al., 2004), and the estrogen re-
ceptor (Nye et al., 2002; Rafique et al., 2015). The molecular
details of these decompact chromatin structures are yet to
be elucidated.
The loss of bound GR from target loci, despite the continued
presence of the agonist, is reminiscent of the state of tolerance
elicited in macrophages by lipopolysaccharide (Seeley and
Ghosh 2017). Most explanations for GC resistance in human
patients are based upon the regulation of cellular responsive-
ness by extrinsic signals, such as inflammatory cytokines and
bacterial products (Bekhbat et al., 2017; Dendoncker and Libert
2017; Silverman et al., 2013; Silverman and Sternberg 2012).
Consistent with that view, the response of the mouse BMDMs
studied herein, and by others (Oh et al., 2017), is acutely regu-
lated by CSF-1 (Hume and Gordon 1984). Persistent changes in
chromatin structure, and a failure to rapidly return to the chro-
matin ground state that existed before GC exposure, suggest
an additional mechanism that may contribute. Chromatin reor-
ganization at key target loci in response to GR binding could
alter the likelihood of those loci being regulated by a future
stimulus. However, the effects of GC are often context specific
(Klengel et al., 2013) and primary macrophages in culture
evolve over time. It remains to be seen whether sustained chro-
matin decompaction can be observed in monocyte/macro-
phages derived from GC-treated patients and whether this is
associated with either therapeutic efficacy, or the development
of GC resistance.
EXPERIMENTAL PROCEDURES
Ethics
Animals were cared for and managed within the Roslin Institute’s Biological
Research Facility following Institute guidelines. The Roslin Institute is
committed to the highest standards of animal welfare and the University of
Edinburgh is a signatory of the Concordat on Openness on Animals in
Research in the UK. No interventions were performed on live animals for this
research.
Cell Culture
The 8- to 10-week male wild-type C57BL/6 mice were culled by cervical dislo-
cation. Bone marrow was flushed from hindlimbs and then cultured in RPMI
supplemented with penicillin/streptomycin, Glutamax (Invitrogen), and 10%
fetal calf serum for 7 days in the presence of 104 U/mL rhCSF-1. The resulting
mBMDMs were replated onto Superfrost microscope slides (Thermo) at
53 105 cells/mL and treated as indicated with 100 nM Dex (Sigma) or ethanol
vehicle. Where described, cells were pre-treated with 2.5 mg/mL a-amanitin
(Sigma) for 4 hr. Dex was washed out by removal of ligand-containing medium,
washing gently once with fresh medium and then returning to culture in further
fresh medium.
Chromatin Immunoprecipitation
Antibodies used for chromatin immunoprecipitation of mouse GR were
BuGR2 (1 mg/106 cells; Thermo Fisher/Pierce) and rabbit IgG sc-2025 (Santa
Cruz).
To prepare antibody-bound beads, 20 mL of Protein A Dynabeads (Invitro-
gen) per immunoprecipitation (IP) were washed once, and then diluted to
200 mL in block solution (13 PBS, 0.5% BSA, +2 mL of 0.1 M PMSF). Antibody
was added and rotated for 3 hr at 4C.
Table 2. Fosmid Clones
Locus
Whitehead
Fosmid Name
Map Position (Chromosome:
Sequence Range)
Fkbp5 WI1-1951C9 chr17:28621896–28660104
Fkbp5 WI1-980F19 chr17:28504480–28545426
Tmod1 WI1-2441L4 chr4:46121795–46162130
Tmod1 WI1-552C3 chr4:45995494–46038724
Ms4xxx WI1-1714F1 chr19:11344410–11380699
Ms4xxx WI1-794B24 chr19:11607184–11647412
Klhl6 WI1-593E13 chr16:19778756–19815279
Klhl6 WI1-1540E20 chr16:19986135–20022250
Dst WI1-2074K18 chr1:34007075–34047561
Dst WI1-1520P06 chr1:34311167–34352486
Tns1 WI1-2221B20 chr1:74136897–74174845
Tns1 WI1-501O4 chr1:73867180–73908234Cells were washed gently once with PBS, cross-linked in tissue culture
plates with 1% formaldehyde/RPMI at room temperature for 10 min, and
then quenched with 0.125 M glycine. Cells were detached by scraping in
PBS, and then spun down (400 3 g, 5 min, 4C), resuspended, and counted.
106 cells per IP were lysed for 15 min on ice in 1% SDS, 10 mM EDTA, 50 mM
Tris-HCl, pH 8.1, supplemented with protease inhibitors (Calbiochem), 1 mM
DTT, and 0.2 mM PMSF (Sigma). The solution was diluted in IP dilution buffer
(0.1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-HCl, pH 8.1) and
sonicated using a Soniprep 150 to produce 300- to 500-bp average fragment
sizes. Chromatin was spun for 10 min at 10,000 3 g (4C), and then supple-
mented with 20% Triton X-100 to 1%, and BSA (Sigma) to 50 mg/mL. Input
aliquots were removed and stored at 20C. Chromatin was then added to
the antibody-bound Protein A Dynabeads (Life Technologies) and rotated
overnight at 4C. After binding, beads were washed 3 3 10 min each in the
following: (1) 1% IP dilution buffer; (2) 1% Triton X-100/0.1% Na-deoxycho-
late/0.1% SDS, 50 mM HEPES, pH 7.9, 500 mM NaCl, 1 mM EDTA; and
(3) 0.5% Na-deoxycholate/0.5% NP-40, 20 mM Tris-HCl, pH 8, 1 mM EDTA,
and 250 mM LiCl. Chromatin was extracted at 37C for 15 min on a vibrating
platform in 100 mL of extraction buffer (0.1 M NaHCO3, 1% SDS). To reverse
cross-links, samples were supplemented to 300 mM with NaCl, treated
with RNaseA (20 mg) (Roche), and then incubated for 8 hr at 65C.
Proteinase K (40 mg) (Genaxxon) was added, and samples were incubated at
55C for 1 hr. DNA was purified using the QIAquick PCR purification kit
(QIAGEN). Real-time qPCR analysis to determine percent input bound at
known GR target loci was carried out on a LightCycler 480 System using
SYBR Green Master Mix (Roche).
Primers
Primers are listed in Table 1.
3D DNA FISH
Paraformaldehyde (pFA)-fixed cells were permeabilized in 0.5% Triton X-100,
washed in PBS, and stored at 80C. 3D-FISH was carried out as previously
described (Eskeland et al., 2010). Slides were imaged and analyzed as
described previously (Williamson et al., 2012). The statistical significance of
differences in n (values in figure legends) measured inter-probe distances
was assessed using the nonparametric Wilcoxon rank sum test in R. Fosmid
clones were from BACPAC Resource Center (Oakland, CA) and are listed in
Table 2.DATA AND SOFTWARE AVAILABILITY
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Figure S1. GR binding precedes detectable rises in Fkbp5 mRNA and is lost by 24h. Related to 
Fig 1. (A) Percent of GR binding sites in mBMDM treated with Dex that overlap with the given 
features in un-treated mBMDMs. Comparison is between our previous GR data (Jubb et al., 2016) and 
published data for PU.1 binding, H3K4me1, H3K27ac, FAIRE-seq and H3K4me3 (Ostuni et al., 2013). 
Blue; data for GR peaks. Orange; data for a GC matched genome permuted background set of peaks. 
(B) Glucocorticoid receptor binding in Dex treated mBMDM measured by ChIP-qPCR for the 
downstream enhancer (+65kb), promoter and upstream enhancer (-28kb) of Fkbp5. Data is shown for a 
4 point time series (baseline, 5min, 15min,1h) of treatment with 100nM dexamethasone. Normal IgG is 
also shown. Error bars are 2 x standard error of the mean (SEM) for 3 technical replicates. This data is 
a biological replicate of the data shown in Figure 1C. (C) Glucocorticoid receptor binding measured by 
ChIP-qPCR for the downstream enhancer (Fkbp5+65kb) following stimulation with 100nM 
dexamethasone at 1 hour and 24h with (1h+23w) and without (24h) washout of the ligand. Error bars 
are 2 x standard error of the mean (SEM) for 3 technical replicates. This is a biological replicate of the 
data in Figure 1G. 
 
 
 
Figure S2. Illustrative DNA FISH images. Related to Figures 1, 2, 3 and 4. (A-F) Images of DNA 
FISH from each of the studied loci at the time points indicated. These images are presented for 
illustration purposes and represent merged 3D image stacks. Data collection was performed in 3D as 
described previously (Eskeland et al., 2010). 
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Supplementary figure S2. Further Illustrative DNA FISH images for each of the tested loci
 
 
	
 
Figure S3. Tmod1 does not have GR bound in the same TAD. Related to Figure 2. Very wide view 
from the UCSC genome browser of the Tmod1 locus that shows no GR bound within either of the two 
sets of Topology Associated Domains (TADs) reported in (Dixon et al., 2012) using HindIII and NcolI 
restriction enzymes, TADs shown in black above locus. 	
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Figure S4. Locations of additional fosmid probes used for 3D DNA FISH. Related to Figures 1, 2, 
3 and 4. (A) UCSC Genome browser image showing Klhl6 / B3gnt5 / Klhl24 gene locus with ChIP-seq 
data (tags/bp) for GR binding from (Jubb et al. 2016). Red and green blocks show the positions of 
fosmid probes used for FISH analysis (mm9). (B & C) analogous images to (A) for Tns1 and Dst. 
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Supplementary figure S4. Positions of additional fosmid probes used for 3D DNA FISH
  
 
 
Figure S5. Glucocorticoid receptor binding is not present at two further target loci 24h after 
treatment. Related to Figure 4. Glucocorticoid receptor binding in Dex treated mBMDM measured 
by ChIP-qPCR at Tns1 and Ms4xxx loci following stimulation with 100nM dexamethasone. Data is 
shown for 1 hour and 24h with (1h+23w) and without (24h) washout of the ligand. Error bars are 2 x 
standard error of the mean (SEM) for 3 technical replicates. 
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Supplementary figure S5. GR is no longer bound 24h following treatment with dexamethasone
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